Related Experiment Videos
Laboratory tests for neuroendocrine tumours.
E Seregni1, L Ferrari, M Stivanello
1Nuclear Medicine Division, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy. ebombar@tin.it
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|August 10, 2000
Summary
This review highlights key laboratory tests for diagnosing neuroendocrine tumors (NETs). It discusses their prognostic significance and the clinical value of specific biomarker evaluation for patient follow-up.
Area of Science:
- Oncology
- Biochemistry
- Clinical Diagnostics
Background:
- Neuroendocrine tumors (NETs) are characterized by hormone hypersecretion, leading to debilitating syndromes.
- Sensitive assays for measuring these substances have improved in vitro patient follow-up.
- Selecting appropriate in vitro tests for NET management is challenging due to low incidence and numerous biomarkers.
Purpose of the Study:
- To review essential laboratory tests for NET diagnosis.
- To discuss the prognostic significance of these tests.
- To evaluate the clinical utility of specific biomarkers in NET patient follow-up.
Main Methods:
- Literature review of diagnostic and prognostic laboratory tests for NETs.
- Analysis of biomarker evaluation in the follow-up of NET patients.
- Focus on biomarkers for gastroenteropancreatic, sympatho-adrenal, prostate, and breast neuroendocrine tumors.
Main Results:
- Identification of the most useful laboratory tests for NET diagnosis.
- Assessment of the prognostic value of various biomarkers.
- Evaluation of the clinical utility of specific markers in NET management.
Conclusions:
- Laboratory tests are crucial for NET diagnosis and prognosis.
- Specific biomarker evaluation aids in effective patient follow-up.
- This review provides guidance for selecting appropriate in vitro examinations for NET management.